局部麻醉与周围神经阻滞在杂交下肢血运重建中的应用与结局
基于ACS-NSQIP数据库2005-2017年8981例杂交下肢血运重建患者,比较局部麻醉/周围神经阻滞联合监护麻醉(LPMAC)与全身麻醉(GA)的围手术期结局。倾向评分匹配后,LPMAC与较低总体并发症率和较短手术时间相关,但死亡率与住院时间无差异。
要点
- LPMAC在杂交下肢血运重建中仅占3.9%,多用于合并症负担重的患者。
- 匹配后LPMAC总体并发症率25.5% vs GA 32.3%(p=0.042),手术时间更短(202.7±98 vs 217.7±102分钟,p=0.034)。
- 心肌梗死(1.1% vs 2.4%)和机械通气>48小时(0.4% vs 2.6%)在LPMAC组数值更低但未达统计学显著性。
核心结论
- LPMAC是杂交下肢血运重建中不常用的麻醉技术,主要用于高合并症负担患者,与降低总体并发症率和缩短手术时间相关。
研究设计与样本
- 回顾性队列研究,检索ACS-NSQIP数据库2005-2017年,纳入9430例因外周动脉疾病行杂交下肢血运重建患者,排除449例后分析8981例。
- 按麻醉方式分为GA组8631例(96.1%)和LPMAC组350例(3.9%),基于倾向评分按3:1匹配后比较801例GA与267例LPMAC。
主要发现
- 未匹配比较中,LPMAC组年龄更大(72.7±9 vs 68±8.4岁,p<0.001),COPD(24.3% vs 17%,p=0.001)、透析依赖(8.1% vs 4.2%,p=0.002)、术前脓毒症(6.6% vs 4.2%,p=0.029)和ASA≥IV级(29.1% vs 24.1%,p=0.036)比例更高。
- 匹配比较中,LPMAC组总体并发症率更低(25.5% vs 32.3%,p=0.042),手术时间更短(202.7±98 vs 217.7±102分钟,p=0.034)。
- 匹配比较中,LPMAC组心肌梗死率(1.1% vs 2.4%)和机械通气>48小时比例(0.4% vs 2.6%)数值更低但未达统计学显著性;死亡率与住院时间无差异。
临床怎么用
- 对于合并症负担重的杂交下肢血运重建患者,可考虑LPMAC以降低总体并发症并缩短手术时间。
- 需进一步研究明确哪些患者从LPMAC中获益最大。
局限性
- LPMAC组样本量小(350例,匹配后267例),部分结局比较可能把握度不足。
- 回顾性数据库研究,可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To investigate the utilization of local anesthesia or peripheral nerve block with monitored anesthesia care (LPMAC) and its impact on the perioperative outcomes of hybrid lower extremity revascularization (LER) compared with general anesthesia (GA). Materials and Methods: A search of the ACS-NSQIP database between 2005 and 2017 identified 9430 patients who underwent hybrid LER for peripheral artery disease. Excluding 449 ineligible cases left 8981 hybrid LER patients for analysis. The patients were dichotomized based on the anesthetic technique: 8631 (96.1%) GA and 350 (3.9%) LPMAC. The GA patients were matched 3:1 based on propensity scores to patients in the LPMAC group based on gender, age, race, functional status, transfer status, chronic obstructive pulmonary disease (COPD), dialysis status, American Society of Anesthesiologists (ASA) class, emergent surgery, preoperative sepsis, indication, and type of open and endovascular procedure. Outcomes including complications, mortality, procedure time, and hospital length of stay were compared between the matched groups (801 GA vs 267 LPMAC). Results: Comparing the unmatched groups, those treated under LPMAC were older (72.7±9 vs 68±8.4 years, p<0.001) and had higher rates of COPD (24.3% vs 17%, p=0.001), dialysis dependence (8.1% vs 4.2%, p=0.002), preoperative sepsis (6.6% vs 4.2%, p=0.029), and ASA class ≥IV (29.1% vs 24.1%, p=0.036) than in the unmatched GA cohort. In the matched comparison, LPMAC was associated with lower overall morbidity (25.5% vs 32.3%, p=0.042) and shorter operating time (202.7±98 vs 217.7±102 minutes, p=0.034) compared with GA. The rate of myocardial infarction was lower (1.1% vs 2.4%) and ventilator use for >48 hours was less frequent (0.4% vs 2.6%) for LPMAC patients, though statistical significance was not reached. There was no difference in mortality or hospital length of stay. Conclusion: LPMAC is an infrequent anesthetic technique for hybrid LER and is primarily used for patients with a high burden of comorbidities. LPMAC is associated with reduced overall morbidity and operating time. Further studies are needed to identify which patients undergoing hybrid LER benefit most from LPMAC.
引用
- Fereydooni A, O'Meara T, Popescu WM, et al. Utilization and Outcomes of Local Anesthesia and Peripheral Nerve Block for Hybrid Lower Extremity Revascularization. J Endovasc Ther. 2019. PMID: 31746264. doi:10.1177/1526602819887382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。